Liver cancer study finds optimal timing for transplants after immunotherapy

Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new cases and 830,200 deaths were registered in 2020, according to the World Health Organization. In Switzerland, the Statistics Office lists 960 new cases and 720 deaths every year. HCC is the third cause of death due to cancer in the world and fifth in Switzerland.